|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.56% | -1.05% | -13.32% | -31.43% | 230B | ||
| -1.09% | -1.56% | -42.66% | -55.99% | 40.29B | ||
| -0.83% | -2.17% | -42.32% | -54.38% | 20.21B | ||
| -0.98% | -2.73% | -45.16% | -68.50% | 15.49B | ||
| -0.59% | +3.24% | +9.10% | +39.17% | 10.55B | ||
| -1.23% | -2.76% | -45.53% | -71.64% | 8.41B | ||
| -0.74% | -0.60% | +10.15% | -46.00% | 8.16B | ||
| -4.10% | -6.27% | -43.00% | -68.13% | 6.42B | ||
| -1.04% | -4.00% | -31.87% | -55.72% | 5B | ||
| Average | -1.12% | -2.37% | -27.18% | -45.85% | 38.32B | |
| Weighted average by Cap. | -0.00% | -1.15% | -20.24% | -37.51% |
- Stock Market
- Stocks
- Stock
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
















